Research

We invite novel laboratory research proposals and clinical investigations pertaining to cancer affecting women in areas such as:
  • Tumor Biology
  • Novel Molecular Targets
  • Companion Diagnostics
  • Improvement in Quality of Life
  • Hereditary Cancer Genetics

Scientific Advisors

The Lewin Fund's scientific advisors are world-renowned leaders in women's cancer research. They review proposals consistent with the mission and priorities of The Lewin Fund.

NADEEM ABU-RUSTUM, MD

CHIEF GYNECOLOGY SERVICE
Professor, Weill Cornell Medical College
Vice Chair Technology, Department of Surgery
Memorial Sloan-Kettering Cancer Center
New York, New York

CHRISTOPHER S. AWTREY, MD

ASSISTANT PROFESSOR, OBSTETRICS AND GYNECOLOGY
Harvard Medical School
Beth Israel Deaconess Medical Center
Boston, Massachusetts

ROBERT L. COLEMAN, MD

PROFESSOR, DEPARTMENT OF GYNECOLOGIC ONCOLOGY AND REPRODUCTIVE MEDICINE,
VICE CHAIR, CLINICAL RESEARCH
Ann Rife Cox Chair in Gynecology
The University of Texas
MD Anderson Cancer Center
Houston, Texas

RAMI EITAN, MD

DEPARTMENT OF OBSTETRICS AND GYNECOLOGY
Faculty of Medicine
Sackler School of Medicine
Tel Aviv University
Ramat Aviv, Israel

JENNIFER KLEMP, PHD, MPH, MA

FOUNDER/CEO, CANCER SURVIVORSHIP TRAINING, INC.
Associate Professor of Medicine, Division of Clinical Oncology
Director, Cancer Survivorship
Cancer Risk and Genetic Counseling
University of Kansas Cancer Center
Kansas City, Kansas

ALYSON MOADEL-ROBBLEE, PHD

PROFESSOR
Department of Epidemiology & Population Health
Division of Health Promotion and Nutrition Research
Department of Medicine, Division of Oncology
Director, Psychosocial Oncology/BOLD Program
Albert Einstein Cancer Center
Bronx, New York

The Lewin Fund to Fight Women’s Cancers invites novel laboratory research proposals and clinical investigations pertaining to women’s cancers from investigators who aim to make critical headway in areas such as tumor biology, novel molecular targets, companion diagnostics, improvement in quality of life and hereditary cancer genetics. Our Scientific Advisors will review proposals consistent with the mission and priorities of The Lewin Fund.

The Lewin Fund runs a continuous grant cycle and uses a two-step application and peer review process. Letters of Intent (LOIs) undergo a rigorous peer review by our Scientific Advisors. We request that all LOI proposals be submitted via email to grants@thelewinfund.org. After LOI review, applicants who fulfill the mission of the The Lewin Fund and pass scientific advisory review will be invited to submit full applications. The awards will be publicly announced after final approval

The Lewin Fund's monetary grant of up to $50,000 per year is typically awarded for two years and will apply only to direct costs. These grants are awarded on a yearly basis contingent upon the review of the first progress report and recommendation of the Scientific Advisors and the executive director of The Lewin Fund.

COMMITMENT TO GRANTEES

We take the review process seriously and are committed to our grantees and offer transparent and confidential interactions with all potential grantees. Deliberations, written critiques of proposals and other materials are kept private during the proposal process. Each reviewer must sign a confidentiality and conflict-of-interest statement.

We welcome and encourage our grantees' feedback because we know that our success and impact depends upon strong, mutually-beneficial relationships with all of our partners.

View the Lewin Fund Science Grant Application Instructions